what happened was, a long time ago in 2021, there was a really bad fire in a building in New York City. Lots of people were very sad and scared because the fire was so big and it hurt a lot of people. Some people even got very sick and could not get better. The people who make sure that people are safe in buildings decided that they needed to change some rules to make sure that fires like that never happen again. So they made a new rule that says when there is a fire, people need to stay in their rooms and not go out until the firefighters say it is safe to come out. This new rule helps to keep everyone safe and protect them from getting hurt by fires. Now, when people talk about "the new fire rule" or "the fire code," they are talking about this rule that was made to keep everyone safe. Read from source...

Overall, the article seemed to present a generally positive outlook on Medtronic's recent earnings report, noting that it had beaten expectations in several areas, including overall sales and adjusted EPS. However, the article also acknowledged some mixed signals in the company's overall performance, such as the 2.8% YoY increase in revenue, which was lower than consensus estimates, and the relatively flat guidance for the year ahead. While the overall tone of the article seemed to be one of cautious optimism about Medtronic's future prospects, there were some criticisms raised about the company's performance and potential challenges that it may face going forward, such as ongoing supply chain disruptions, competitive pressures, and changing market dynamics. Overall, while the article provided some useful insights and analysis about Medtronic's recent performance and outlook, it also highlighted some potential risks and uncertainties that investors should be aware of when considering this stock for their portfolios.

Medtronic Plc (MDT) reported better-than-expected results for its first quarter on Tuesday. The company posted first-Quarter 2025 sales of $7.92 billion, beating the consensus of $7.89 billion. The medical device maker reported adjusted EPS of $1.23, beating the consensus of $1.20. Revenue increased 2.8% year over year, as reported, and 5.3% organic. Medtronic revised its fiscal year 2025 adjusted EPS guidance to $5.42 – $5.50, compared to prior guidance of $5.40 – $5.50 and consensus of $5.44. The company sees fiscal year 2025 organic revenue growth of 4.5% – 5% compared to prior guidance of 4% – 5%.

### DAVE:
US stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.10% to 40,854.31 while the NASDAQ fell 0.15% to 17,850.34. The S&P 500 also fell, dropping 0.06% to 5,604.70. Health care shares climbed by 0.5% on Tuesday. In trading on Tuesday, energy shares fell by 1%. In Asia Pacific markets, Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.

### FRANK:
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while the current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy' s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July. In commodity news, oil traded up 0.8% to $74.96 while gold traded up 1.1% at $2,568.90. Silver traded up 2% to $29.875 on Tuesday, while copper rose 0.2% to $4.1875.

### LISA:
No major economic reports are scheduled for release today. Stocks that are trading lower include energy shares, which fell by 1%. Equities that are trading up include health care shares, which climbed by 0.5%. InMed Pharmaceuticals Inc. (INM) shares shot up 250% to $0.5075 after the company announced that INM-901 will be used in its development programs for Alzheimer’ s Disease